Model for end-stage liver disease: end of the first decade.
about
Model for End-stage Liver DiseaseHepatic disease biomarkers and liver transplantation: what is the potential utility of microRNAs?Impact of different creatinine measurement methods on liver transplant allocation.Plasma Amino Acid Concentrations Predict Mortality in Patients with End-Stage Liver Disease.Addressing geographic disparities in liver transplantation through redistricting.Is liver transplantation using organs donated after cardiac death cost-effective or does it decrease waitlist death by increasing recipient death?Thromboelastographic reference ranges for a cirrhotic patient population undergoing liver transplantation.An acute change in lung allocation score and survival after lung transplantation: a cohort study.Recalibrating the Child-Turcotte-Pugh Score to Improve Prediction of Transplant-Free Survival in Patients with Cirrhosis.Organ donor allocation system for liver transplantation in the Kingdom of Saudi Arabia: Call for major revision.Higher Mortality in registrants with sudden model for end-stage liver disease increase: Disadvantaged by the current allocation policy.Predictive value of Refit Model for End-Stage Liver Disease, Refit Model for End-Stage Liver Disease-Na, and pre-existing scoring system for 3-month mortality in Korean patients with cirrhosis.Quantitative assessment of global hepatic glycolysis in patients with cirrhosis and normal controls using 18F-FDG-PET/CT: a pilot study.Predicting early allograft failure and mortality after liver transplantation: the role of the postoperative model for end-stage liver disease score.Successful introduction of Model for End-stage Liver Disease scoring in deceased donor liver transplantation in Korea: analysis of first 1 year experience at a high-volume transplantation centerPrevalence and Prognosis of Portopulmonary Hypertension in 223 Liver Transplant Recipients
P2860
Q26864971-950A61E3-729E-4263-B796-E03BAEB60244Q30456435-EACCF5B7-5563-4191-A266-6B3A12DC9B37Q35108569-E4F0A913-703C-45C2-B2E7-04F2BF9F266AQ36075660-B4138748-9DF4-4AC3-9729-A36B375C24C5Q36359189-2387BA9A-C4DC-4150-909F-087246D8DD91Q36609355-C516EFC7-5195-4BEF-8F34-276669C5C68FQ37282201-74CCAEB8-91BD-4C68-841B-9281188A5A8AQ37285800-7C8F92C0-A561-4698-9FB3-7C3455903B1EQ37344902-24A79C71-D613-488B-92C5-C5D58C2438A9Q43189378-25BA17EA-7306-4C3D-99D8-5639C92B7579Q44949104-792E89FB-BFB3-45AB-8C17-E7BE4DB787CEQ50870578-BAEC6B13-5F86-4B9D-BB55-B8DD74843CA7Q53090438-B39FFB01-AA25-4398-BC1C-2EE362A66DE9Q53112362-A878577D-89B1-4A7E-A0D5-C1D6229A24DBQ57217580-1EFF2AB0-F941-4580-80E6-16964B097AC2Q57493072-DCCC7614-2A75-4E7C-A771-E80383D7AA30
P2860
Model for end-stage liver disease: end of the first decade.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Model for end-stage liver disease: end of the first decade.
@ast
Model for end-stage liver disease: end of the first decade.
@en
type
label
Model for end-stage liver disease: end of the first decade.
@ast
Model for end-stage liver disease: end of the first decade.
@en
prefLabel
Model for end-stage liver disease: end of the first decade.
@ast
Model for end-stage liver disease: end of the first decade.
@en
P2860
P1476
Model for end-stage liver disease: end of the first decade
@en
P2093
Sumeet K Asrani
P2860
P304
P356
10.1016/J.CLD.2011.08.009
P577
2011-10-01T00:00:00Z